Verrica Pharmaceuticals, Inc. (VRCA)
7.99
-0.25
(-3.03%)
USD |
NASDAQ |
May 08, 16:00
7.95
-0.04
(-0.50%)
After-Hours: 20:00
Verrica Pharmaceuticals Shareholders Equity (Quarterly) : 24.74M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Lipocine, Inc. | 22.83M |
| Cognition Therapeutics, Inc. | 29.91M |
| Corcept Therapeutics, Inc. | 637.99M |
| Assertio Holdings, Inc. | 93.95M |
| Johnson & Johnson | 81.19B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 47.52M |
| Total Liabilities (Quarterly) | 22.78M |
| Debt to Equity Ratio | 0.0659 |
| Current Ratio | 2.469 |
| Net Debt Paydown Yield | 11.84% |